Clinical outcome and prognostic factors in hepatocellular carcinoma patients with bone metastases medicated with zoledronic acid

  • Zoledronic acid for bone metastases from HCC
  • Yohji Honda, Hiroshi Aikata, Fumi Honda, Norihito Nakano, Yuki Nakamura, Masahiro Hatooka, Kei Morio, Tomoki Kobayashi, Takayuki Fukuhara, Yuko Nagaoki, Tomokazu Kawaoka, Akira Hiramatsu, Michio Imamura, Yoshiiku Kawakami, Kazuaki Chayama
  • Hepatology Research, December 2016, Wiley
  • DOI: 10.1111/hepr.12844

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1111/hepr.12844

In partnership with: